The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons

Molecular Pharmacology

Volumn 56, Issue 3, 1999, Pages 581-587

  Szallasi, Arpad ^a,c   Blumberg, Peter M ^a   Annicelli, Lauren L ^b   Krause, James E ^b   Cortright, Daniel N ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NEUROGEN CORPORATION   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANILLOID RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; LIGAND BINDING; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; SPINAL GANGLION;

EID: 0032876069     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.3.581     Document Type: Article

References (38)

1. Ács G, Bíró T, Ács P, Modarres S and Blumberg PM (1997) Differential activation and desensitization of sensory neurons by resiniferatoxin. J Neurosci 17:5622-5628.
2. 45Ca uptake and for high affinity binding in cultured rat dorsal root ganglion neurons and dorsal root ganglion membranes. Mol Brain Res 35:173-182.
3. Ács G, Lee J, Marquez VE, Wang S, Milne GWA, Du L, Lewin NE and Blumberg PM (1995) Resiniferatoxin-amide and analogues as ligands for protein kinase C and vanilloid receptors and determination of their biological activities as vanilloids. J Neurochem 65:301-308.
4. Bevan S, James IF, Rang HP, Winter J and Wood JN (1987) The mechanism of action of capsaicin - a sensory neurotoxin, in Neurotoxins and Their Pharmacological Applications (Jenner P ed) pp 261-277, Raven Press, New York.
5. Bevan S and Szolcsányi J (1990) Sensory neuron-specific actions of capsaicin: Mechanisms and applications. Trends Pharmacol Sci 11:330-333.
6. Bíró T, Ács G, Ács P, Modarres S and Blumberg PM (1997) Recent advances in understanding of vanilloid receptors: A therapeutic target for treatment of pain and inflammation in skin. J Invest Dermatol Symp Proc 2:56-60.
7. Bíró T, Brodie C, Modarres S, Lewin NE, Ács P and Blumberg PM (1998a) Specific vanilloid responses in C6 glioma cells. Mol Brain Res 56:89-98.
8. Bíró T, Maurer M, Modarres S, Lewin NE, Brodie C, Ács G, Ács P, Paus R and Blumberg PM (1998b) Characterization of functional vanilloid receptors expressed by mast cells. Blood 4:1332-1340.
9. Brand LM, Skare KL, Loomans ME, Reller HH, Schwen RJ, Lade DA, Bohne RL, Maddin CS, Moorehead DP, Fanelli R, Chiabrando C, Castelli MG and Tai HH (1990) Antiinflammatory pharmacology and mechanisms of the orally active capsaicin analogs, NE-19950 and NE-28345. Agents Actions 31:329-340.
10. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD and Julius D (1997) The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature (Lond) 389:816-824.
11. Cruz F, Guimarães M, Silva C and Reis M (1997) Suppression of bladder hyperreflexia by intravesical resiniferatoxin. Lancet 350:640-641.
12. Dickenson AH and Dray A (1991) Selective antagonism of capsaicin by capsazepine: Evidence for a spinal receptor site in capsaicin-induced antinociception. Br J Pharmacol 104:1045-1049.
13. Hautkappe M, Roizen MF, Toledano A, Roth S, Jeffries JA and Ostermeier AM (1998) Review of the effectiveness of capsaicin for painful cutaneous disorders and neural dysfunction. Clin J Pain 14:97-106.
14. Holzer P (1991) Capsaicin: Cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 43:144-201.
15. Lazzeri M, Spinelli M, Beneforti P, Zanollo A and Turini D (1998) Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord disease. Scand J Urol Nephrol 32:331-334.
16. ++ dependence in rat trigeminal ganglion cells. J Neurophysiol 75:1503-1514.
17. Maggi CA (1992) Therapeutic potential of capsaicin-like molecules: Studies in animals and humans. Life Sci 51:1777-1781.
18. Maggi CA, Bevan S, Walpole CSJ, Rang HP and Giuliani S (1993) A comparison of capsazepine and ruthenium red as capsaicin antagonists in the rat isolated urinary bladder and vas deferens. Br J Pharmacol 108:801-805.
19. Petersen M, LaMotte RH, Klusch A and Kniffki KD (1996) Multiple capsaicin-evoked currents in isolated rat sensory neurons. Neuroscience 75:495-505.
20. Szallasi A (1994) The vanilloid (capsaicin) receptor: Receptor types, species differences. Gen Pharmacol 25:223-243.
21. Szallasi A, Bíró T, Modarres S, Garlaschelli L, Petersen M, Klusch A, Vidari G, Jonassohn M, DeRosa S, Sterner O, Blumberg PM and Krause JE (1998) Dialdehyde sesquiterpenes and other terpenoids as vanilloids. Eur J Pharmacol 356:81-89.
22. Szallasi A, Bíró T, Szabó T, Modarres S, Petersen M, Klusch A, Blumberg PM, Krause JE and Sterner O (1999a) A non-pungent triprenyl phenol of fungal origin, scutigeral, stimulates rat dorsal root ganglion neurons via interaction at vanilloid receptors. Br J Pharmacol 126:1351-1358.
23. Szallasi A and Blumberg PM (1989) Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capssaicin, the irritant constituent in red pepper. Neuroscience 30:515-520.
24. Szallasi A and Blumberg PM (1990a) Resiniferatoxin and analogs provide novel insights into the pharmacology of vanilloid (capsaicin) receptors. Life Sci 47:1399-1408.
25. Szallasi A and Blumberg PM (1990b) Specific binding of resiniferatoxin, an ultrapotent capsaicin analog, by dorsal root ganglion membranes. Brain Res 524:106-111.
26. Szallasi A and Blumberg PM (1996) Vanilloid receptors: New insights enhance potential as a therapeutic target. Pain 68:195-208.
27. Szallasi A and Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51:159-211.
28. Szallasi A, Jonassohn M, Ács G, Bíró T, Ács P and Blumberg PM (1996) The stimulation of capsaicin-sensitive neurones in a vanilloid receptor-mediated fashion by pungent terpenoids possessing an unsaturated 1,4-dialdehyde moiety. Br J Pharmacol 119:283-290.
29. 1-acid glycoprotein (orosomucoid) as a major vanilloid-binding protein in serum. J Pharmacol Exp Ther 262:883-888.
30. Szallasi A, Lewin NE and Blumberg PM (1993) Vanilloid (capsaicin) receptor in the rat: Positive cooperativity of resiniferatoxin binding and its modulation by reduction and oxidation. J Pharmacol Exp Ther 266:678-683.
31. Szallasi A, Szabó T, Bíró T, Modarres S, Blumberg PM, Krause JE, Cortright DN and Appendino G (1999b) Resiniferatoxin-type phorboid vanilloids display capsaicin-like selectivity at native vanilloid receptors on rat DRG neurons and at the cloned vanilloid receptor VRI. Br J Pharmacol, in press.
32. Szolcsányi J, Szallasi A, Szallasi Z, Joó F and Blumberg PM (1990) Resiniferatoxin, an ultrapotent selective modulator of capsaicin-sensitive primary afferent neurons. J Pharmacol Exp Ther 255:923-928.
33. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI and Julius D (1998) The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21:531-543.
34. Walpole CSJ, Bevan S, Bloomfield G, Breckenridge R, James IF, Ritchie T, Szallasi A, Winter J and Wrigglesworth R (1996) Similarities and differences in the structure-activity relationships of capsaicin and resiniferatoxin analogues. J Med Chem 30:2939-2952.
35. Walpole CSJ and Wrigglesworth R (1993) Structural requirements for capsaicin agonists and antagonists, in Capsaicin in the Study of Pain (Wood JN ed) pp 63-82, Academic Press, San Diego.
36. Winter J, Dray A, Wood JN, Yeats JC and Bevan S (1990) Cellular mechanism of action of resiniferatoxin: A potent sensory neurotoxin. Brain Res 520:131-140.
37. Winter J, Walpole CSJ, Bevan S and James IF (1993) Characterization of resiniferatoxin binding sites on sensory neurons: Co-regulation of resiniferatoxin binding and capsaicin sensitivity in adult dorsal root ganglia. Neuroscience 57:747-757.
38. Wood JN, Winter J, James IF, Rang HP, Yeats J and Bevan S (1988) Capsaicin-induced ion fluxes in dorsal root ganglion cells in culture. J Neurosci 8:3208-3220.